Director Larry Robbins' Investment Funds Sell Over $352M in CVS Stock
CVS sits 59% above its 52-week low of $58.5.
Summary
Director Larry Robbins' managed investment funds sold over $352 million worth of CVS Health common stock and cash-settled swaps, marking a significant reduction in their holdings.
Key Events · Ownership and Investor Activity · CVS
-
Significant Insider Sale
Director Larry Robbins, through Glenview Investment Funds, sold 3,750,000 shares of common stock and 378,000 units of cash-settled swaps.
-
Total Value Exceeds $352 Million
The combined value of these transactions was $352,742,694, executed between May 19 and May 21, 2026.
-
Indirect Ownership
The shares and swaps were held indirectly by Glenview Investment Funds, where Mr. Robbins serves as Founder, Portfolio Manager, and CIO.
-
Post-Transaction Holdings
After these sales, the funds hold 6,213,412 shares.
Analysis · CVS · Trade & Services
Director Larry Robbins, through investment funds he manages, executed a substantial sale of CVS Health common stock and cash-settled swaps totaling over $352 million. This significant disposition by a director, even if through managed funds, represents a notable reduction in exposure and could be interpreted as a portfolio rebalancing decision or a shift in conviction.
At the time of this filing, CVS was trading at $92.83 on NYSE in the Trade & Services sector, with a market capitalization of approximately $119.1B. The 52-week trading range was $58.50 to $98.43. This filing was assessed with negative market sentiment and an importance score of 7 out of 10.